|
Code
|
6220D
|
|
MA number
|
15/0287/20-S
|
|
Product Form:
|
plc ifc 5x500 mg (liek.inj.skl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
hameln pharma gmbh, Germany
|
|
Therapeutic Class:
|
15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 |
ANTIBACTERIALS FOR SYSTEMIC USE |
| J01F |
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| J01FA |
Macrolides |
| J01FA09 |
Clarithromycin |
|
|
Shelf life:
|
60 |
|
Container:
|
vial
|
|
Route of admin.:
|
Intravenous use
|
PIL_Clarithromycin hameln 500 mg plc ifc_10.2024.pdf
